Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP-214 in chronic phase or elderly schizophrenia
NCT01625897Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- May 2012
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of cariprazine in schizophrenia, sponsored by Mitsubishi Tanabe Pharma. Started May 2012; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01625897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01625897.